FdaApplication
ANDA 212160
Identifiers
- fda_app_no: ANDA212160
Properties
| Property | Value |
|---|---|
| applicant_name | WINDER LABORATOIRIES LLC |
| application_type | ANDA |
| approval_date | 2021-06-07 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | 7.5MG | TABLET;ORAL |
| DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | 30MG | TABLET;ORAL |
| DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | 15MG | TABLET;ORAL |
| DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | 5MG | TABLET;ORAL |
| DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | 10MG | TABLET;ORAL |
| DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | 2.5MG | TABLET;ORAL |
| DEXTROAMPHETAMINE SULFATE | DEXTROAMPHETAMINE SULFATE | 20MG | TABLET;ORAL |
7 products